Developing Regulatory RNA-based Therapeutics for DEEs and an ASO to Increase SYNGAP Gene Expression

Camp4 Therapeutics Corporation published this content on September 24, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 02, 2025 at 08:32 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]